Early-Life Height Attainment in Cystic Fibrosis Is Associated with Pulmonary Function at Age 6 Years

Don B Sanders1, James E Slaven2, Karen Maguiness1

  • 1Division of Pulmonology, Allergy and Sleep Medicine, Department of Pediatrics, and.

Insights

Maintaining height-for-age (HFA) above the 50th percentile in early childhood is linked to better lung function in children with cystic fibrosis (CF). This study highlights HFA as a key indicator for respiratory health in CF patients.

Area of Science:

  • Pediatric Pulmonology
  • Cystic Fibrosis Research
  • Growth and Development

Background:

  • Early-life weight for age and body mass index (BMI) are known predictors of lung disease in cystic fibrosis (CF).
  • The association between height-for-age (HFA) percentiles and respiratory morbidity in early childhood CF is less understood.
  • Understanding growth trajectories is crucial for predicting long-term health outcomes in children with CF.

Purpose of the Study:

  • To investigate the association between changes in height-for-age (HFA) percentiles during the first six years of life and pulmonary function.
  • To determine if early-life HFA trajectories predict lung function (FEV1) at ages 6-7 years in children with CF.

Main Methods:

  • Retrospective longitudinal cohort study using the CF Foundation Patient Registry (2003-2010 births).
  • Analysis of annualized HFA changes categorized into distinct trajectories.
  • Multivariable analysis of covariance models to assess the relationship between HFA trajectories and percent-predicted forced expiratory volume in 1 second (FEV1) at age 6-7 years.

Main Results:

  • A cohort of 5,388 children with CF met the inclusion criteria.
  • Children consistently maintaining HFA above the 50th percentile demonstrated significantly higher percent-predicted FEV1 at ages 6-7 years.
  • Decreases in HFA by ≥10 percentile points were associated with lower FEV1, with a correlation noted between nadir HFA and FEV1.

Conclusions:

  • Consistently high HFA (above 50th percentile) in early childhood is associated with optimal pulmonary function in school-aged children with CF.
  • While maintaining BMI above the 50th percentile is important, HFA trajectory is a critical, independent marker for evaluating nutritional status and predicting respiratory outcomes.
  • Monitoring HFA trends provides valuable insights into respiratory health trajectories in pediatric CF patients.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
552
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
314
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.5K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
549
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
924
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89